Allergan
Allergan, officially known as Allergan plc, is a prominent global pharmaceutical company headquartered in the United States. Founded in 1948, Allergan has established itself as a leader in the biopharmaceutical industry, focusing on areas such as medical aesthetics, eye care, and neuroscience. The company is renowned for its innovative products, including the widely recognised Botox, which has transformed both cosmetic and therapeutic treatments.
With major operational regions spanning North America, Europe, and Asia, Allergan has achieved significant milestones, including its acquisition by AbbVie in 2020, further solidifying its market position. The company’s commitment to research and development has led to a diverse portfolio of unique offerings, making it a key player in enhancing patient outcomes and quality of life.
-2 vs industry average
Allergan’s score of 36 is higher than 59% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Allergan?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
Scope 3 accounts for ••• of total emissions.
Allergan's reported carbon emissions
In 2017, Allergan, headquartered in the US, reported total carbon emissions of approximately 250 million kg CO2e. This figure includes 88.2 million kg CO2e from Scope 1 emissions, 46.8 million kg CO2e from Scope 2 emissions (market-based), and 250 million kg CO2e from Scope 3 emissions. The company has consistently reported significant Scope 3 emissions, which have remained at 250 million kg CO2e since 2015. Allergan's emissions data is cascaded from its parent company, AbbVie Inc., indicating a corporate family relationship that influences its climate commitments. However, Allergan has not set specific reduction targets or initiatives as part of its climate strategy, and there are no documented reduction initiatives or SBTi targets available. Overall, Allergan's commitment to addressing climate change remains unclear, with no specific pledges or reduction targets outlined in the available data. The company continues to report its emissions transparently, but further action may be necessary to align with industry standards for climate commitments.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Allergan’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Allergan yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
Inherited from AbbVie Inc.
Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisations
Allergan
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project